Andrew Hill Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-41
Closed -$9K 56
2021
Q4
$9K Buy
+41
New +$8.65K 0.01% 163

Other funds holding AMGN

Andrew Hill Investment Advisors's AMGN Position: Q1 2022 in Review

Andrew Hill Investment Advisors sold out of Amgen (AMGN) in Q1 2022, closing a stake of 41 shares — an estimated $9K sold.

Andrew Hill Investment Advisors first reported a position in AMGN in Q4 2021 and held it in 1 quarter. The position peaked at $9K in Q4 2021. 2,338 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.

  • Andrew Hill Investment Advisors reported no remaining Amgen position as of Q1 2022 after selling out during the quarter.
  • Andrew Hill Investment Advisors sold 41 Amgen shares in Q1 2022, an estimated $9K.
  • Andrew Hill Investment Advisors first reported a position in Amgen in Q4 2021 and held it in 1 quarter.
  • Andrew Hill Investment Advisors's Amgen position peaked at $9K in Q4 2021.
  • 2,338 funds tracked by Wall St. Rank held Amgen as of Q1 2022.

Based on Andrew Hill Investment Advisors's 13F filing for Q1 2022, filed 11 May 2022.